ISGIDAR 2022 Program

Our annual meeting is just around the corner, and we’re excited to share the program (below). As a reminder, ISGIDAR 2022, our next meeting that will be held in conjunction with the 2022 CPDD meeting in Minneapolis, Minnesota on June 11th, 2022. We have an excellent lineup of speakers and look forward to seeing their talks! Thank you, to everyone who submitted an abstract and to Dr. Banks for putting together an outstanding program.

Newsletter: Hear more about the goings on of ISGIDAR in the annual newsletter here.

Registration: Register for the ISGIDAR meeting through the CPDD meeting registration site (Registration Link). The registration fee for this year’s meeting is $100 for regular attendees and is $50 for in-training attendees. We will be following similar COVID-19 protocols as CPDD for the ISGIDAR meeting. ISGIDAR will require all attendees to be fully vaccinated to attend the in-person meeting. ISGIDAR will allow for a medical exemption form for those immunocompromised or otherwise advised not to receive the vaccine by their medical professional. ISGIDAR will adhere to CDC guidelines regarding masking, social distancing, etc for our in-person meeting.

Look forward to seeing everyone in June!

image1

REMINDER: If you have updated contact information or know of colleagues who have recently moved, please assist us in forwarding this information on and encouraging them to reach out to us with their new contact information!

ISGIDAR always welcomes TAX-DEDUCTIBLE CONTRIBUTIONS. If you would like to make a tax-deductible contribution go to https://squareup.com/store/isgidarcom

Note: Our content management system occasionally places third-party advertisements on this website. ISGIDAR does not receive income from these advertisements and does not endorse their content.

ISGIDAR CPDD Meeting 2022!

June 11, 2022

Mission

The mission of ISGIDAR is to promote interest in, and to facilitate the dissemination of, new information related to drugs as reinforcers, especially as it may relate to human drug abuse.